Global Anticoagulants Market Major Players 2024, Forecast To 2033
14 Feb, 2024
The anticoagulants market has witnessed rapid growth, escalating from $45.18 billion in 2023 to $49.89 billion in 2024, showcasing a 10.4% compound annual growth rate (CAGR). This growth is attributed to an aging population, increased cardiovascular disease prevalence, rising awareness of anticoagulant therapy, and expanded indications for use. Expected to maintain momentum, the market is forecasted to reach $77.71 billion in 2028, demonstrating an 11.7% CAGR. Contributing factors include novel drug indications, healthcare infrastructure expansion, and the emergence of novel oral anticoagulants. Key trends include advancements in medical technologies, AI integration, and patient education initiatives.
Global Anticoagulants Market Key Driver
The anticoagulants market experiences growth driven by the increasing prevalence of cardiovascular diseases. Cardiovascular diseases claimed 17.9 million lives globally in 2021, with heart attacks and strokes accounting for 85% of these deaths. Anticoagulants play a crucial role in minimizing thrombosis in various cardiovascular conditions. The rising prevalence of cardiovascular diseases fuels the growth of the anticoagulants market.
Get A Free Sample Of The Global Anticoagulants Market ReportGlobal Anticoagulants Market Segments
The anticoagulants market covered in this report is segmented –
1) By Drug Class: Factor Xa Inhibitor, Heparin And LMWH, Vitamin K Antagonist, Other Drug Classes
2) By Route Of Administration: Oral Anticoagulant, Injectable Anticoagulant
3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
4) By Application: Venous Thromboembolism, Atrial Fibrillation Or Flutter, Coronary Artery Disease, Other Applications
5) By End User: Hospitals, Homecare, Specialty Centers, Other End-Users
By Geography: The regions covered in the template market report are Asia-Pacific, Western Europe, Eastern Europe,North America, South America, Middle East, and Africa. Among these regions.
North Americawas the largest region in the anticoagulants market in 2023. The regions covered in the anticoagulants market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Major Anticoagulants Industry Players
GlaxoSmithKline plc; Leo Pharma A/S; Alexion Pharmaceuticals Inc.; Amphastar Pharmaceuticals Inc.; Bayer AG; Boehringer Ingelheim International GmbH; Daiichi Sankyo Company Limited; Eisai Co. Ltd.; Mylan N. V.; Otsuka Holdings Co. Ltd.; Pfizer Inc.; Sanofi S. A.; Apotex Inc.; Aspen Pharmacare Holdings Limited; AstraZeneca plc; Bristol-Myers Squibb Company; CSL Behring; Dr. Reddy's Laboratories Ltd.; Eli Lilly and Company; Fresenius Kabi AG; Hikma Pharmaceuticals plc; Johnson & Johnson; Lupin Limited; Mitsubishi Tanabe Pharma Corporation; Natco Pharma Limited; Novartis International AG; Portola Pharmaceuticals Inc.; Strides Pharma Science Limited; Sun Pharmaceutical Industries Limited; Teva Pharmaceutical Industries Limited; Torrent Pharmaceuticals Limited; Zydus Cadila Healthcare Limited
Get The Full Global Anticoagulants Market Report
Anticoagulants Market Overview
Anticoagulants refer to a drug used to prevent and treat blood clots in the heart and blood arteries. called a blood thinner as well. It is utilized to slow down the body's clotting process. These are blood thinners, but they do not thin the blood, instead, they avoid or minimize clots or thrombi.
Anticoagulants Global Market Report 2023 provides data on the global anticoagulants market such as market size, growth forecasts, segments and geographies, competitive landscape including leading competitors’ revenues, profiles and market shares. The anticoagulants market report identifies opportunities and strategies based on market trends and leading competitors’ approaches.